Volume | 208 |
|
|||||
Noticias | - |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Sunshine Biopharma Inc | SBFMW | NASDAQ | Warrant Capital Accionario |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.21 | 0.21 | 0.24 | 0.24 | 0.24 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
---|---|---|---|---|
6 | 208 | 0.2399999 | 50 | - |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
15:00:00 | 100 | 0.24 | USD |
Información Financiera Sunshine Biopharma Inc SBFMW
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
6.16M | 25.68M | - | 24.09M | -4.51M | -0.18 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Sunshine Biopharma Inc SBFMW
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
21/1/2025 | 07:20 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
15/1/2025 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
06/1/2025 | 10:44 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
10/12/2024 | 15:26 | Edgar (US Regulatory) | Form 8-K - Current report |
14/11/2024 | 15:28 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain.. |
12/11/2024 | 10:29 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
07/11/2024 | 15:40 | Edgar (US Regulatory) | Form 8-K - Current report |
06/11/2024 | 12:43 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
05/11/2024 | 15:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
23/10/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
17/10/2024 | 15:05 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
10/9/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico SBFMW
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |